Ming Xue

Mr. Ming Xue

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
YZYadong Zhou
Yadong Zhou
YGYunbiao Guan
Yunbiao Guan
MXMing Xue
Ming Xue
XZXuexun Zheng
Xuexun Zheng
XCXingsheng Chen
Xingsheng Chen

1 January 2021 in Asian Journal of Surgery
Verified
Journal Article
Open access
YZYadong Zhou
Yadong Zhou
YGYunbiao Guan
Yunbiao Guan
MXMing Xue
Ming Xue
XZXue-Xun Zheng
Xue-Xun Zheng
XCXing-Sheng Chen
Xing-Sheng Chen
This retrospective nonrandomized study investigated the outcomes of endovascular therapy for long-segment iliac artery occlusion involving the iliac artery opening. During a 5-year period (from Mar 2012 to Mar 2017), 32 patients (two women and 30 men; mean age, 69.0 years; range, 51-90 years) received endovascular therapy, with or without catheter-directed thrombolysis (CDT), for long-segment iliac artery occlusion (mean lesion length, 129.8 mm; range, 74.7-189.3 mm). The technical success rate was 90.6% (29 of 32). The major complication rate was 3.5%, but no in-hospital mortality was recorded. The access site complication rate was 10.3%. The clinical symptoms of 29 patients were significantly improved. All 29 patients were followed up for 6-40 months, with an average of 16.7 ± 10.9 months. The primary patency rates were 96.6 ± 3.4% at 6 months, 86.6 ± 7.3% at 12 months, 79.4 ± 9.6% at 24 months, and 66.2 ± 14.5% at 36 months. Depending on the characteristics of the disease, endovascular treatment with an individualized, rational choice of approach and with fine-tuning of the operation is a safe and effective treatment for long-term iliac artery occlusion involving the opening of the iliac arteries. Customization of the treatment is also the key to a successful operation and to ensuring good postoperative efficacy.